ONO onesano S.A.
onesano S.A. engages in the production of products related to nutritional cycle, from agricultural production, through animal breeding, to dietetics and human supplementation in Poland. The company offers omega-3, 6, and 9 fatty acids; postbiotic Yarrowia lipolytica Novel Food, solutions in animal nutrition and dietetics; solutions in the field of bioremediation for hydrocarbon-contaminated soil based on the unique postbiotic Yarrowia lipolytica; veterinary products. It also provides dietary supplements and nutraceuticals under the EstroVita and PostVital brands; veterinary products under the Equinox and Canifelox brands; fortified foods and feed products; and natural agricultural products, as well as the production of contract brands and food raw materials. It sells its products through chain pharmacies, pharmaceutical wholesalers, drugstores, and develops sales through e-commerce platforms. The company was formerly known as Skotan SA and changed its name to onesano S.A. in March 2023. onesano S.A. was incorporated in 2001 and is headquartered in Chorzów, Poland.…
Industry Peers
ChemicalsKey Statistics
About onesano (WSE: ONO)
›
onesano (WSE: ONO) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Chemicals industry, part of the Basic Materials sector, and reports about 42 employees.
The shares were at 0.6820 PLN on 20 November 2026, down 24.2% over 52 weeks. Its 52-week range is 0.5000 PLN to 0.9920 PLN: the price is 31.3% below the high and 36.4% above the low.
Its market capitalisation is 44.93M PLN.
onesano reports return on equity of -98.5%, an operating margin of -34.8% and revenue up 3.6% year over year.
Its debt exceeds its cash by 1.33M PLN, a debt-to-equity ratio of 0.28. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.